GLYCOSYLATED HAEMOGLOBIN INCREASED
Adverse reaction reported in 18,448 FDA reports across 13 drugs.
18,448
Total Reports
13
Drugs Involved
Insulin Glargine
Most Reported Drug
Drugs Associated with GLYCOSYLATED HAEMOGLOBIN INCREASED
Drugs where "GLYCOSYLATED HAEMOGLOBIN INCREASED" was reported as an adverse event.
| # | Drug | Reports | % of Total |
|---|---|---|---|
| 1 | Insulin Glargine | 4,843 | |
| 2 | Insulin Lispro | 3,174 | |
| 3 | Dulaglutide | 2,932 | |
| 4 | Insulin Aspart | 1,217 | |
| 5 | Empagliflozin | 1,198 | |
| 6 | Insulin Human | 1,056 | |
| 7 | Exenatide | 991 | |
| 8 | Insulin Detemir | 738 | |
| 9 | Liraglutide | 718 | |
| 10 | Insulin Degludec | 555 | |
| 11 | Canagliflozin | 514 | |
| 12 | Human Insulin | 256 | |
| 13 | Insulin Glulisine | 256 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused glycosylated haemoglobin increased. Always consult your healthcare provider.